DW Hommes

Statistics

Publications

Citations

475

H-Index

Active since

1991

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

DW Hommes is an author at Amsterdam UMC Location University of Amsterdam specializing in inflammatory bowel disease, medicine, and inflammatory bowel disease therapy.

Publications per year

1991–2007

Publications

Fontolizumab, a humanised anti-interferon antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease

DW Hommes · Gut · 2005 · 244 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Mortality in hereditary antithrombin-III deficiency—1830 to 1989

F.R. Rosendaal, K. de Bruin, Jan P. Vandenbroucke et al. · The Lancet · 1991 · 72 citations · Full text

Medicine, Hematology, Internal Medicine +9

P178 EARLY CROHN'S DISEASE SHOWS HIGH LEVELS OF REMISSION TO THERAPY WITH ADALIMUMAB: SUB-ANALYSIS OF CHARM

Stefanie Schreiber, Walter Reinisch, J F Colombel et al. · Journal of Crohn s and Colitis Supplements · 2007 · 67 citations · Full text

Medicine, Immunology, Pathology +17

The ideal management of Crohn's disease: Top down versus step up strategies, a randomized controlled trial

DW Hommes, Filip Baert, Gert Van Assche et al. · Ghent University Academic Bibliography (Ghent University) · 2006 · 45 citations

Medicine, Clinical Sciences, Internal Medicine +8

A randomized controlled trial evaluating the ideal medical management for Crohn's disease (CD): Top-down versus step-up strategies

DW Hommes, Filip Baert, Gert Van Assche et al. · Ghent University Academic Bibliography (Ghent University) · 2005 · 35 citations

Medicine, Clinical Sciences, Internal Medicine +11

1–5 of 6